Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
198 USD | +0.87% | +2.94% | +15.12% |
Mar. 06 | ResMed Inc. Announces the U.S. Launch of the AirFit F40 | CI |
Mar. 06 | Morgan Stanley Adjusts Resmed’s Price Target to AU$31.80 From AU$28.60, Keeps at Overweight | MT |
Chart calendar ResMed, Inc.
Upcoming events on ResMed, Inc.
Past events on ResMed, Inc.
2024-02-06 | Ex-dividend day |
2024-01-24 04:30 pm | Q2 2024 Earnings Call |
2024-01-24 04:05 pm | Q2 2024 Earnings Release |
2024-01-08 05:15 pm | JPMorgan Healthcare Conference |
2023-11-16 03:00 pm | Annual General Meeting |
2023-11-07 | Ex-dividend day |
2023-10-26 04:30 pm | Q1 2024 Earnings Call |
2023-10-26 04:05 pm | Q1 2024 Earnings Release |
2023-09-14 11:45 am | Bank of America Global Healthcare Conference - Fireside Chat |
2023-09-12 10:50 am | Morgan Stanley Global Healthcare Conference |
2023-08-15 | Ex-dividend day |
2023-08-03 04:30 pm | Q4 2023 Earnings Call |
2023-08-03 04:05 pm | Q4 2023 Earnings Release |
2023-06-12 12:20 pm | Goldman Sachs Global Healthcare Conference |
2023-05-09 | Ex-dividend day |
2023-04-27 04:30 pm | Q3 2023 Earnings Call |
2023-04-27 04:05 pm | Q3 2023 Earnings Release |
2023-03-21 03:45 pm | KeyBanc Life Sciences & MedTech Forum - Fireside Chat |
2023-03-13 11:20 am | Oppenheimer Healthcare Conference |
2023-02-07 | Ex-dividend day |
Past dividends on ResMed, Inc.
2024-02-06 | Quarterly 0.48 USD |
2023-11-07 | Quarterly 0.48 USD |
2023-08-15 | Quarterly 0.48 USD |
2023-05-09 | Quarterly 0.44 USD |
2023-02-07 | Quarterly 0.44 USD |
2022-11-08 | Quarterly 0.44 USD |
2022-08-16 | Quarterly 0.44 USD |
2022-05-10 | Quarterly 0.42 USD |
2022-02-08 | Quarterly 0.42 USD |
2021-11-08 | Quarterly 0.42 USD |
Annual results
Fiscal Period | Juni | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2 607 2 605 0.04% | 2 957 2 940 0.59% | 3 197 3 116 2.59% | 3 578 3 574 0.11% | 4 223 4 235 -0.29% | 4 640 |
EBITDA Million USD | Released Forecast Spread | 792 776 2.11% | 966 931 3.75% | 1 074 1 064 1.01% | 1 162 1 175 -1.17% | 1 317 1 351 -2.52% | 1 527 |
EBIT Million USD | Released Forecast Spread | 641 630 1.8% | 811 793 2.26% | 904 891 1.45% | 1 000 1 003 -0.26% | 1 224 1 231 -0.55% | 1 417 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 519 588 -11.79% | 733 745 -1.56% | 884 857 3.1% | 960 971 -1.09% | 1 102 1 114 -1.13% | 1 211 |
Net income Million USD | Released Forecast Spread | 405 457 -11.47% | 622 589 5.57% | 475 455 4.21% | 779 780 -0.12% | 898 901 -0.42% | 977 |
EPS USD | Released Forecast Spread | 2,80 3,15 -11.2% | 4,27 4,10 4.02% | 3,24 3,14 3.12% | 5,30 5,29 0.12% | 6,09 6,11 -0.27% | 6,54 |
Announcement Date | 25/07/19 | 05/08/20 | 05/08/21 | 11/08/22 | 03/08/23 | - |
Quarterly results
Fiscal Period | June | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 895 928 -3.59% | 865 900 -3.91% | 915 913 0.24% | 950 947 0.36% | 1 034 996 3.77% | 1 117 1 051 6.31% | 1 122 1 139 -1.53% | 1 102 1 106 -0.32% | 1 163 1 151 1% | 1 173 | 1 195 | 1 156 | 1 206 | 1 199 |
EBITDA Million USD | Released Forecast Spread | 290 315 -8.05% | 277 293 -5.73% | 295 301 -1.98% | 313 314 -0.28% | 326 328 -0.63% | 345 335 3.06% | 333 357 -6.68% | 364 341 6.69% | 390 362 7.98% | 392 | 401 | 372 | 401 | 399 |
EBIT Million USD | Released Forecast Spread | 249 255 -2.3% | 234 251 -6.84% | 255 249 2.57% | 291 281 3.32% | 305 305 0.24% | 321 311 3.31% | 307 326 -5.75% | 319 309 3.12% | 366 342 6.93% | 362 | 371 | 369 | 398 | 369 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 237 249 -4.65% | 226 229 -1.17% | 238 243 -2% | 262 259 1.25% | 274 280 -2.17% | 289 263 10.03% | 277 289 -4.35% | 272 276 -1.54% | 259 316 -17.88% | 329 | 341 | 345 | 366 | 355 |
Net income Million USD | Released Forecast Spread | 202 207 -2.54% | 179 199 -10.22% | 195 196 -0.48% | 210 214 -1.79% | 225 225 0.15% | 233 216 7.86% | 230 233 -1.34% | 219 220 -0.38% | 209 244 -14.4% | 265 | 275 | 271 | 293 | 279 |
EPS USD | Released Forecast Spread | 1,37 1,40 -2.38% | 1,22 1,31 -6.75% | 1,33 1,31 1.53% | 1,43 1,40 2.44% | 1,53 1,53 -0.24% | 1,58 1,47 7.14% | 1,56 1,58 -0.98% | 1,49 1,47 1.13% | 1,42 1,64 -13.54% | 1,77 | 1,84 | 1,78 | 1,94 | 1,89 |
Announcement Date | 27/01/22 | 28/04/22 | 11/08/22 | 27/10/22 | 26/01/23 | 27/04/23 | 03/08/23 | 26/10/23 | 24/01/24 | - | - | - | - | - |
Past sector events for ResMed, Inc.
Today 01:55 am | STRATEC SE: Q4 2023 Earnings Release |
Today | PULSE BIOSCIENCES, INC.: Q4 2023 Earnings Release |
Today | QINGDAO HAIER BIOMEDICAL CO.,LTD: Q4 2023 Earnings Release |
Today | LIFETECH SCIENTIFIC CORPORATION: Q4 2023 Earnings Release |
Today | MICROPORT SCIENTIFIC CORPORATION: Q4 2023 Earnings Release |
2024-03-26 | SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD.: Q4 2023 Earnings Release |
2024-03-07 01:30 am | DRÄGERWERK AG & CO. KGAA: Q4 2023 Earnings Release |
2024-03-06 02:00 am | OXFORD NANOPORE TECHNOLOGIES PLC: Q4 2023 Earnings Release |
2024-02-29 04:00 pm | QUANTERIX CORPORATION: Q4 2023 Earnings Release |
2024-02-29 01:30 am | ELEKTA AB: Q3 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock ResMed, Inc. - Nyse
- Calendar ResMed, Inc.